Mexico approved emergency use of CanSino and Sinovac COVID-19 vaccines

The Under-Secretary for Prevention and Health Promotion, Hugo López-Gatell Ramírez, confirmed that the vaccine manufactured by CanSino organic products and infectious disease experts from the Chinese military, as well as the “CoronaVac” of Sinovac, already have the approval of the Federal Commission for the Protection against Health Risks (Cofepris).

Until yesterday, the only official statement in this regard came from the Asian laboratories themselves.

The CanSino vaccine itself, which has already obtained emergency registration, authorization for emergency use, and the Sinovac vaccine, or Coronavac, which is the brand name of the vaccine. Both of Chinese origin

It is noteworthy that the approval of the CanSino vaccine in the country was broadcast by the British media Financial Times. However, no federal authority has commented on the matter.

Thus, during the last report on the current state of the COVID-19 pandemic in Mexico, the reported today on the approval by the federal agency. On this, the authorities confirmed the inclusion of two other vaccines in the Mexican repertoire of inoculation against the SARS-CoV-2 virus.

Although both vaccines are of Chinese origin, only the one manufactured by the pharmaceutical company Sinovac Biotech will arrive in the country packed. Rather, the organic product produced by CanSino will arrive in bulk and It will be conditioned in the state of Querétaro.

“The CanSino vaccine will be arriving in bulk. In reality Tomorrow we have the first big one that will arrive in Mexico and will be transferred to a factory in Querétaro, indicate where it will be packed. Both vaccines have already received emergency use authorization, ”he said.

In addition, Marcelo Ebrard Casaubón, head of the Ministry of Foreign Affairs, confirmed the next arrival of the consignment to carry out the packaging and labeling of the first doses.

“The authorization of the CanSino and Sinovac vaccines will allow these vaccines to arrive in Mexico soon. For the moment Tomorrow, the first 2 million Cansino will arrive for filling and packaging at Drugmex, Querétaro. Congratulations! “, He announced via his Twitter account.

It was precisely the chancellor who yesterday toured the complex located in the industrial park “El Marqués”. In a video posted on their social networks, the staff declared themselves ready to receive the raw materials and the biopharmaceutical for the total packaging of eight million doses.

Unlike the technology used to create other vaccines such as Pfizer-BioNTech, the manufacturing methods of the one invented by CanSino obeys more traditional techniques. According to National Autonomous University of Mexico (UNAM), an adenovirus (which causes the common cold) is used as a vehicle for some of the novel coronavirus. When injected, the viral particles generate the immune response in the body

Thanks to its technological conditions, the complete scheme requires only one application and does not require freezing conditions. For this reason, health authorities have considered it the ideal vaccine for immunize people who live in areas where it would be impossible to keep other like that of Pfizer-BioNTech.

Until, Mexico’s COVID-19 vaccine repertoire consists of five. Those of CanSinoBio and Sinovac have joined Pfizer-BioNTech, AstraZeneca and Sputnik V to be used in an emerging way.

The COVID-19 vaccine from CanSinoBio has been shown to be 65.7% effective in preventing mild symptomatic cases, as well as 90.98% in the face of serious symptomatic images. For its part, Coronavac is 50.38% effective.

MORE ABOUT THE SUBJECT

This is the packaging plant for the CanSino COVID-19 vaccine in Mexico

Mexico has already approved Chinese vaccine CanSino: Financial Times

Pakistan reported that CanSinoBIO’s one-dose covid-19 vaccine was 65.7% effective in global trials